Analyst Price Target is $9.33
▲ +234.53% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Alpha Teknova in the last 3 months. The average price target is $9.33, with a high forecast of $12.00 and a low forecast of $8.00. The average price target represents a 234.53% upside from the last price of $2.79.
Current Consensus is
The current consensus among 1 investment analysts is to hold stock in Alpha Teknova. This Hold consensus rating has held steady for over two years.
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.